INOVIQ Ltd (ASX:IIQ)
0.3850
+0.0400 (11.59%)
Feb 26, 2026, 3:56 PM AEST
INOVIQ Revenue
INOVIQ had revenue of 1.12M AUD in the half year ending December 31, 2025, with 59.11% growth. This brings the company's revenue in the last twelve months to 2.10M, up 24.48% year-over-year. In the fiscal year ending June 30, 2025, INOVIQ had annual revenue of 1.82M with 16.25% growth.
Revenue (ttm)
2.10M
Revenue Growth
+24.48%
P/S Ratio
23.10
Revenue / Employee
140.16K
Employees
15
Market Cap
48.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.82M | 253.75K | 16.25% |
| Jun 30, 2024 | 1.56M | 10.36K | 0.67% |
| Jun 30, 2023 | 1.55M | -446.01K | -22.33% |
| Jun 30, 2022 | 2.00M | 726.44K | 57.16% |
| Jun 30, 2021 | 1.27M | 735.67K | 137.48% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Healius | 1.37B |
| Australian Clinical Labs | 737.49M |
| Integral Diagnostics | 627.22M |
| Monash IVF Group | 271.92M |
| Genetic Signatures | 19.75M |
| Microba Life Sciences | 15.67M |
| Cryosite | 14.12M |
| Genetic Technologies | 9.17M |